Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 5
2004 10
2005 10
2006 7
2007 7
2008 17
2009 15
2010 13
2011 25
2012 33
2013 29
2014 33
2015 51
2016 39
2017 31
2018 30
2019 32
2020 42
Text availability
Article attribute
Article type
Publication date

Search Results

354 results
Results by year
Filters applied: . Clear all
Page 1
EGFR TKI combination with immunotherapy in non-small cell lung cancer.
Ahn MJ, Sun JM, Lee SH, Ahn JS, Park K. Ahn MJ, et al. Among authors: lee sh. Expert Opin Drug Saf. 2017 Apr;16(4):465-469. doi: 10.1080/14740338.2017.1300656. Epub 2017 Mar 8. Expert Opin Drug Saf. 2017. PMID: 28271729 Review.
Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09).
Cho JH, Lim SH, An HJ, Kim KH, Park KU, Kang EJ, Choi YH, Ahn MS, Lee MH, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Cho JH, et al. Among authors: lee sh. J Clin Oncol. 2020 Feb 10;38(5):488-495. doi: 10.1200/JCO.19.00931. Epub 2019 Dec 11. J Clin Oncol. 2020. PMID: 31825714 Free PMC article. Clinical Trial.
New Approaches to SCLC Therapy: From the Laboratory to the Clinic.
Poirier JT, George J, Owonikoko TK, Berns A, Brambilla E, Byers LA, Carbone D, Chen HJ, Christensen CL, Dive C, Farago AF, Govindan R, Hann C, Hellmann MD, Horn L, Johnson JE, Ju YS, Kang S, Krasnow M, Lee J, Lee SH, Lehman J, Lok B, Lovly C, MacPherson D, McFadden D, Minna J, Oser M, Park K, Park KS, Pommier Y, Quaranta V, Ready N, Sage J, Scagliotti G, Sos ML, Sutherland KD, Travis WD, Vakoc CR, Wait SJ, Wistuba I, Wong KK, Zhang H, Daigneault J, Wiens J, Rudin CM, Oliver TG. Poirier JT, et al. Among authors: lee sh. J Thorac Oncol. 2020 Apr;15(4):520-540. doi: 10.1016/j.jtho.2020.01.016. Epub 2020 Feb 1. J Thorac Oncol. 2020. PMID: 32018053 Review.
The transcriptional landscape and mutational profile of lung adenocarcinoma.
Seo JS, Ju YS, Lee WC, Shin JY, Lee JK, Bleazard T, Lee J, Jung YJ, Kim JO, Shin JY, Yu SB, Kim J, Lee ER, Kang CH, Park IK, Rhee H, Lee SH, Kim JI, Kang JH, Kim YT. Seo JS, et al. Among authors: lee sh. Genome Res. 2012 Nov;22(11):2109-19. doi: 10.1101/gr.145144.112. Epub 2012 Sep 13. Genome Res. 2012. PMID: 22975805 Free PMC article.
Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma.
Kim N, Kim HK, Lee K, Hong Y, Cho JH, Choi JW, Lee JI, Suh YL, Ku BM, Eum HH, Choi S, Choi YL, Joung JG, Park WY, Jung HA, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ, Lee HO. Kim N, et al. Among authors: lee sh. Nat Commun. 2020 May 8;11(1):2285. doi: 10.1038/s41467-020-16164-1. Nat Commun. 2020. PMID: 32385277 Free PMC article.
Recombinant Glargine Insulin Production Process Using Escherichia coli.
Hwang HG, Kim KJ, Lee SH, Kim CK, Min CK, Yun JM, Lee SU, Son YJ. Hwang HG, et al. Among authors: lee sh. J Microbiol Biotechnol. 2016 Oct 28;26(10):1781-1789. doi: 10.4014/jmb.1602.02053. J Microbiol Biotechnol. 2016. PMID: 27363479 Free article.
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load.
Jung H, Kim HS, Kim JY, Sun JM, Ahn JS, Ahn MJ, Park K, Esteller M, Lee SH, Choi JK. Jung H, et al. Among authors: lee sh. Nat Commun. 2019 Sep 19;10(1):4278. doi: 10.1038/s41467-019-12159-9. Nat Commun. 2019. PMID: 31537801 Free PMC article.
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort.
Chow LQM, Haddad R, Gupta S, Mahipal A, Mehra R, Tahara M, Berger R, Eder JP, Burtness B, Lee SH, Keam B, Kang H, Muro K, Weiss J, Geva R, Lin CC, Chung HC, Meister A, Dolled-Filhart M, Pathiraja K, Cheng JD, Seiwert TY. Chow LQM, et al. Among authors: lee sh. J Clin Oncol. 2016 Nov 10;34(32):3838-3845. doi: 10.1200/JCO.2016.68.1478. Epub 2016 Sep 30. J Clin Oncol. 2016. PMID: 27646946 Free PMC article.
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial.
Cho J, Kim HS, Ku BM, Choi YL, Cristescu R, Han J, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Cho J, et al. Among authors: lee sh. J Clin Oncol. 2019 Aug 20;37(24):2162-2170. doi: 10.1200/JCO.2017.77.3184. Epub 2018 Jun 15. J Clin Oncol. 2019. PMID: 29906252 Clinical Trial.
Pembrolizumab for the treatment of non-small cell lung cancer.
Lim SH, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Lim SH, et al. Among authors: lee sh. Expert Opin Biol Ther. 2016;16(3):397-406. doi: 10.1517/14712598.2016.1145652. Expert Opin Biol Ther. 2016. PMID: 26800463
354 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback